Is the newest angiotensin‐receptor blocker azilsartan medoxomil more efficacious in lowering blood pressure than the older ones? A systematic review and network meta‐analysis-Reference-Cited by-同舟云学术

Is the newest angiotensin‐receptor blocker azilsartan medoxomil more efficacious in lowering blood pressure than the older ones? A systematic review and network meta‐analysis

Published:2021-02-20 Issue:5 Volume:23 Page:901-914
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertens

Author:

Wang Ji‐Guang¹^ORCID,Zhang Miao²,Feng Ying‐Qing³,Ma Chang‐Sheng⁴,Wang Tzung‐Dau⁵^ORCID,Zhu Zhi‐Ming⁶^ORCID,Kario Kazuomi⁷^ORCID

Affiliation:

1. The Shanghai Institute of HypertensionRuijin HospitalShanghai Jiaotong University School of Medicine Shanghai China

2. Medical Affairs Takeda Pharmaceuticals Ltd Shanghai China

3. Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou China

4. Department of Cardiology Beijing Anzhen Hospital Beijing China

5. Cardiovascular Center and Divisions of Hospital Medicine and Cardiology Department of Internal Medicine National Taiwan University Hospital and National Taiwan University College of Medicine Taipei City Taiwan

6. Chongqing Hypertension Institute Department of Hypertension and Endocrinology Daping Hospital The Third Military Medical University Chongqing China

7. Division of Cardiovascular Medicine Department of Medicine Jichi Medical University School of Medicine Tochigi Japan

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jch.14227

Reference48 articles.

1. Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals

2. Differential pharmacology and benefit/risk of azilsartan compared to other sartans

3. The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

4. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

5. Network meta-analysis for indirect treatment comparisons

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review;Terapevticheskii arkhiv;2023-11-03

2. Therapeutic Implications of Renin–Angiotensin System Modulators in Alzheimer’s Dementia;Pharmaceutics;2023-09-06

3. Pharmacoeconomic analysis of the modern inhibitors of the renin‑angiotensin system in patients with arterial hypertension in the Russian Federation;"Arterial’naya Gipertenziya" ("Arterial Hypertension");2023-08-10

4. Two-Drug Combinations Therapy of Different Doses of Valsartan Existing Diverse Significance for Hypertensive Patients;Reviews in Cardiovascular Medicine;2023-06-29

5. Interventions for reducing blood pressure in prehypertension: A meta-analysis;Frontiers in Public Health;2023-03-23